Correction: Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer

Correction: Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-07-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/7/e011198corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer
by: David D Limbrick, et al.
Published: (2025-06-01)

Trifunctional antibody-cytokine fusion protein formats for tumor-targeted combination of IL-15 with IL-7 or IL-21
by: Annika M. Möller, et al.
Published: (2025-04-01)

Enhanced Immunity and Infection Resistance in Mice Through Co-Expression of Porcine IL-3, IL-7, and IL-15 Fusion Molecules in <i>Yarrowia lipolytica</i>
by: Junjie Peng, et al.
Published: (2025-04-01)

Correction: Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Published: (2021-10-01)

Inhibition of TGF-β1 Signaling by IL-15: A Novel Role for IL-15 in the Control of Renal Epithelial-Mesenchymal Transition: IL-15 Counteracts TGF-β1-Induced EMT in Renal Fibrosis
by: Aurore Devocelle, et al.
Published: (2019-01-01)

Antitumor power of oncolytic HSV engineered with IL-12 and IL-15
by: Lei Zhang, et al.
Published: (2025-09-01)

Discovery and development of ANV419, an IL-2/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy
by: Patrizia Murer, et al.
Published: (2024-12-01)

IL-15 functionalized biomimetic hybrid mRNA vaccine for enhanced NSCLC immunotherapy via synergistic activation of T cells and NK cells
by: Jueshuo Guo, et al.
Published: (2025-06-01)

New perspectives in cancer immunotherapy: targeting IL-6 cytokine family
by: Maria Florencia Soler, et al.
Published: (2023-11-01)

Co-expression of IL-15/IL-15Ra complex enhances NKG2D-CAR T cell-mediated anti-pancreatic cancer immunity by activating the JAK/STAT5 signaling pathway
by: Yiran Chen, et al.
Published: (2025-06-01)

IL-15: from discovery to FDA approval
by: Zihai Li, et al.
Published: (2025-02-01)

Plant-derived Pembrolizumab in conjugation with IL-15Rα-IL-15 complex shows effective anti-tumor activity
by: Kaewta Rattanapisit, et al.
Published: (2025-01-01)

Plant-derived Pembrolizumab in conjugation with IL-15Rα-IL-15 complex shows effective anti-tumor activity.
by: Kaewta Rattanapisit, et al.
Published: (2025-01-01)

Engineered tumor specific AAV for IL-12 delivery in ovarian cancer immunotherapy
by: Fan Tong, et al.
Published: (2025-08-01)

Head-to-head: IL-21 triumphs over IL-15 in NK cell therapy for glioblastoma
by: Miller Jake C., et al.
Published: (2025-01-01)

The Enhancement of Immunity Gained from Feline Trivalent Vaccines in Mice Using Feline IL-15, IL-23 and Metabolic Regulatory Molecules
by: Ruichen Gao, et al.
Published: (2025-07-01)

Correction: Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
Published: (2020-05-01)

Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapy
by: Yue Zhao, et al.
Published: (2025-07-01)

IL-24 producing regulatory T and B lymphocytes in endometriosis
by: Anna Ewa Kedzierska, et al.
Published: (2025-06-01)

IL-2 immunotherapy rescues irradiation-induced T cell exhaustion in mouse colon cancer
by: Carmen S.M. Yong, et al.
Published: (2025-06-01)

Correction: Enhanced anti−tumor efficacy of “IL−15 and CCL19” −secreting CAR−T cells in human glioblastoma orthotopic xenograft model
by: Wanqiong Chen, et al.
Published: (2025-08-01)

Amendment to 'Correction: Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19'
Published: (2020-10-01)

Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression
by: Simon Gebremeskel, et al.
Published: (2022-03-01)

Evaluation of the degree of clinical rheumatoid arthritis activity based on the concentrations of cytokines TNF-alpha, IL-12, IL-15, and IL-18 in serum and synovial fluid
by: Petrović-Rackov Ljiljana
Published: (2006-01-01)

Vitamin D stimulates Il-15 synthesis in rodent muscle
by: Franz Ewendt, et al.
Published: (2025-03-01)

IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors
by: Jessica Wagner, et al.
Published: (2024-11-01)

Nuclear CD24 promotes IL-6 secretion in fibroblasts
by: Yuqiao Sheng, et al.
Published: (2025-04-01)

Metabolic reprogramming of naïve regulatory T cells by IL-7 and IL-15 promotes their persistence and performance upon adoptive transfer
by: Jessica Filoni, et al.
Published: (2025-01-01)

Phenotypic Profile of Peripheral Blood NK Cells under Culturing with Trophoblast Cells and IL-15 and IL-18 Cytokines
by: V. A. Mikhailova, et al.
Published: (2021-12-01)

Correction: Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy
Published: (2024-11-01)

Curcumin liposomes attenuate the expression of cigarette smoke extract-induced inflammatory markers IL-8 and IL-24 in vitro
by: Vyoma K. Patel, et al.
Published: (2024-06-01)

The distinct role of IL-34 and IL-35 in gastric cancer
by: Zhiyun He, et al.
Published: (2025-05-01)

The significant role of IL-15, IL-22, IL-37, and caspase 9 in polycystic ovary syndrome: A case-control study in a sample of Iraqi women
by: Noor A. Mohammed, et al.
Published: (2025-03-01)

Targeting IL‐17A to manage immunotherapy‐induced toxicity in melanoma
by: Kai Huang
Published: (2025-01-01)

Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation.
by: Sanjay Swaminathan, et al.
Published: (2016-01-01)

Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2v
by: Ulrich Moebius, et al.
Published: (2025-04-01)

Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy
by: Kengo Tanigawa, et al.
Published: (2025-12-01)

The Possible Role of the Novel Cytokines IL-35 and IL-37 in Inflammatory Bowel Disease
by: Yanmei Li, et al.
Published: (2014-01-01)

Safety and efficacy of canine recombinant IL-15 in mammary gland tumors
by: Min-Hee Kang, et al.
Published: (2025-06-01)

The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations.
by: Vasile Laza-Stanca, et al.
Published: (2011-07-01)